Characterizing lobular carcinoma of the male breast using the SEER database

Journal of Surgical Research

Volumn 185, Issue 2, 2013, Pages

  Moten, Ambria ^a   Obirieze, Augustine ^a   Wilson, Lori L ^a,b  

^a HOWARD UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b HOWARD UNIVERSITY HOSPITAL   (United States)

Author keywords

Breast surgery; Health disparity; Lobular carcinoma; Male breast cancer; Outcomes

Indexed keywords

ADULT; AGED; BREAST CARCINOMA; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER REGISTRY; CANCER RISK; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HUMAN; ICD-O-3; MAJOR CLINICAL STUDY; MALE; MALE BREAST CANCER; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PARTIAL MASTECTOMY; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SEX DIFFERENCE; SURVIVAL RATE; TUMOR DIFFERENTIATION; VERY ELDERLY; YOUNG ADULT; AGE DISTRIBUTION; ARTICLE; BREAST SURGERY; BREAST TUMOR; CANCER GRADING; HEALTH DISPARITY; INCIDENCE; LUNG CARCINOMA; MORTALITY; OUTCOMES; PATHOLOGY; PROPORTIONAL HAZARDS MODEL; RISK FACTOR; SEX RATIO; STATISTICS; BREAST NEOPLASMS, MALE; CARCINOMA, LOBULAR; STATISTICS AND NUMERICAL DATA;

BREAST SURGERY; HEALTH DISPARITY; LOBULAR CARCINOMA; MALE BREAST CANCER; OUTCOMES;

ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS, MALE; CARCINOMA, LOBULAR; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NEOPLASM GRADING; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; SEER PROGRAM; SEX DISTRIBUTION; YOUNG ADULT;

EID: 84891683642     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2013.05.043     Document Type: Article

References (24)

1. American Cancer Society. Breast cancer in men detailed guide. Atlanta: American Cancer Society; 2012.
2. Hill TD, Khamis HJ, Tyczynski JE, Berkel HJ. Comparison of male and female breast cancer incidence trends, tumor characteristics, and survival. Ann Epidemiol 2005;15:773.
3. Koc M, Oztas S, Erem TM, Ciftcioglu AK, Onuk DM. Invasive lobular carcinoma of the male breast: a case report. Jpn J Clin Oncol 2001;31:444.
4. Erhan Y, Zekioglu O, Erhan Y. Invasive lobular carcinoma of the male breast. Can J Surg 2006;49:365.
5. Rohini B, Singh PA, Vatsala M, Vishal D, Mitali S, Nishant S. Pleomorphic lobular carcinoma in a male breast: a rare occurrence. Pathol Res Int 2010;2010:871369.
6. Maly B, Maly A, Pappo I, Meir K, Pappo O. Pleomorphic variant of invasive lobular carcinoma of the male breast. Virchows Arch 2005;446:344.
7. Mariolis-Sapsakos T, Theodoropoulos G, Flessas II, et al. Lobular breast cancer in men: case report and review of the literature. Onkologie 2010;33:698.
8. Briest S, Vang R, Terrell K, Emens L, R Lange J. Invasive lobular carcinoma of the male breast: a rare histology in an uncommon disease. Breast Care (Basel) 2009;4:36.
9. Scheidbach H, Dworak O, Schmucker B, Hohenberger W. Lobular carcinoma of breast in an 85-year-old man. Eur J Surg Oncol 2000;26:319.
10. Surveillance, Epidemiology, and End Results (SEER) Program. Research data (1973-2008), www.seer.cancer.gov. National Cancer Institute, Division of Cancer Control and Population Services, Surveillance Research Program, Surveillance Systems Branch, released May 2011 [accessed].
11. McLaughlin JM, Fisher JL, Paskett ED. Marital status and stage at diagnosis of cutaneous melanoma: results from the Surveillance Epidemiology and End Results (SEER) program, 1973-2006. Cancer 2011;117:1984.
12. Arpino G, Bardou VJ, Clark GM, Elledge RM. Infiltrating lobular carcinoma of the breast: tumor characteristics and clinical outcome. Breast Cancer Res 2004;6:R149.
13. Vo TN, Meric-Bernstam F, Yi M, et al. Outcomes of breast-conservation therapy for invasive lobular carcinoma are equivalent to those for invasive ductal carcinoma. Am J Surg 2006;192:552.
14. Winchester DJ, Chang HR, Graves TA, Menck HR, Bland KI, Winchester DP. A comparative analysis of lobular and ductal carcinoma of the breast: presentation, treatment, and outcomes. J Am Coll Surg 1998;186:416.
15. Vandorpe T, Smeets A, Van Calster B, et al. Lobular and non-lobular breast cancers differ regarding axillary lymph node metastasis: a cross-sectional study on 4, 292 consecutive patients. Breast Cancer Res Treat 2011;128: 429.
16. Dian D, Herold H, Mylonas I, et al. Survival analysis between patients with invasive ductal and invasive lobular breast cancer. Arch Gynecol Obstet 2009;279:23.
17. Bharat A, Gao F, Margenthaler JA. Tumor characteristics and patient outcomes are similar between invasive lobular and mixed invasive ductal/lobular breast cancers but differ from pure invasive ductal breast cancers. Am J Surg 2009;198: 516.
18. Singletary SE, Patel-Parekh L, Bland KI. Treatment trends in early-stage invasive lobular carcinoma: a report from the National Cancer Data Base. Ann Surg 2005; 242:281.
19. Henry-Tillman RS, Klimberg VS. In situ breast cancer. Curr Treat Options Oncol 2000;1:199.
20. Gump FE, Kinne D, Schwartz GF. Current treatment for lobular carcinoma in situ. Ann Surg Oncol 1998;5:33.
21. Carson W, Sanchez-Forgach E, Stomper P, Penetrante R, Tsangaris TN, Edge SB. Lobular carcinoma in situ: observation without surgery as an appropriate therapy. Ann Surg Oncol 1994;1:141.
22. Cocquyt V, Van Belle S. Lobular carcinoma in situ and invasive lobular cancer of the breast. Curr Opin Obstet Gynecol 2005;17:55.
23. Li CI, Anderson BO, Daling JR, Moe RE. Trends in incidence rates of invasive lobular and ductal breast carcinoma. JAMA 2003;289:1421.
24. Akashi-Tanaka S, Fukutomi T, Nanasawa T, Matsuo K, Hasegawa T, Tsuda H. Treatment of noninvasive carcinoma: fifteen-year results at the National Cancer Center Hospital in Tokyo. Breast Cancer 2000;7:341.